Solid Biosciences Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Solid Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2024.
  • Solid Biosciences Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $107M.
  • Solid Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.12M, a 95.8% decline from 2022.
  • Solid Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $74.8M, a 44.6% decline from 2021.
  • Solid Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $135M, a 4.88% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $107M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2022 $22K* -$135M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $135M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q1 2018 $132M +$107M +431% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q1 2017 $24.8M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.